neutral endopeptidase determines the severity of pancreatitis-associated lung injury

2
EDITORIAL Neutral Endopeptidase Determines the Severity of Pancreatitis-Associated Lung Injury In this issue of the Journal of Surgical Research, Kirkwood et al., from the University of California at San Francisco examine the anti- inflammatory effects of the ubiquitous cell surface protease, neutral endo- peptidase (NEP). The authors specifically examined the ability of NEP to inhibit the pulmonary inflammatory response in pancreatitis associated lung injury, or PALI, when induced by elastase. Pulmonary insufficiency is a common and relentless morbidity seen in patients with severe acute pancreatitis and a primary cause of their mortality. The pulmonary histology from affected patients commonly re- veals inflammatory cell sequestration and microvascular injury. Activated inflammatory cells in the lung lead, via both direct and indirect means, to the release of a cascade of pro-inflammatory mediators [1]. The mecha- nisms by which pancreatitis activates this pulmonary inflammatory re- sponse are incompletely understood but candidate etiologies include noci- ceptive neuronal activation [2], interleukins 6 and 10 [3] heat shock protein 60 [4], nitric oxide [5], and TNF- and STAT-3 [6]. These authors also propose IL1-, oxygen free radicals, and platelet-activating factor as potential biological mediators [7]. NEP is a cell-surface metalloprotease that catalyzes and deactivates proinflammatory peptides and is an appealing therapeutic target for the treatment of the lung injury associated with pancreatitis or sepsis. Neutralization of NEP worsens both experimental pancreatitis and the coupled lung injury. In this study, the authors used a murine model of PALI to test their hypothesis: that NEP antagonism, or its genetic deletion, would enhance inflammation and pulmonary damage irrespec- tive of the extent of pancreatitic inflammation. Using NEP knockout mice, the investigators were able to show conclusively that NEP is an inhibitor of pancreatic elastase-induced lung injury, in all probability via degradation of pro-inflammatory mediators, in both models. These results also support the effectiveness of the elastase-induced lung in- jury model in studying respiratory insufficiency associated with acute pancreatitis. This manuscript is important as it describes NEPs ability to degrade a variety of pro-inflammatory mediators thereby underpinning the salient role of NEP in PALI. These experiments portend a therapeutic role for neutral endopeptidase in improving the relentless lung injury seen in acute pancreatitis. David McFadden, M.D. Editor Journal of Surgical Research 128, 1–2 (2005) doi:10.1016/j.jss.2005.07.021 1 0022-4804/05 $30.00 © 2005 Elsevier Inc. All rights reserved.

Upload: david-mcfadden

Post on 25-Oct-2016

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Neutral Endopeptidase Determines the Severity of Pancreatitis-Associated Lung Injury

Journal of Surgical Research 128, 1–2 (2005)doi:10.1016/j.jss.2005.07

EDITORIAL

Neutral Endopeptidase Determines the Severityof Pancreatitis-Associated Lung Injury

In this issue of the Journal of Surgical Research, Kirkwood et al., fromthe University of California at San Francisco examine the anti-inflammatory effects of the ubiquitous cell surface protease, neutral endo-peptidase (NEP). The authors specifically examined the ability of NEP toinhibit the pulmonary inflammatory response in pancreatitis associatedlung injury, or PALI, when induced by elastase.

Pulmonary insufficiency is a common and relentless morbidity seen inpatients with severe acute pancreatitis and a primary cause of theirmortality. The pulmonary histology from affected patients commonly re-veals inflammatory cell sequestration and microvascular injury. Activatedinflammatory cells in the lung lead, via both direct and indirect means, tothe release of a cascade of pro-inflammatory mediators [1]. The mecha-nisms by which pancreatitis activates this pulmonary inflammatory re-sponse are incompletely understood but candidate etiologies include noci-ceptive neuronal activation [2], interleukins 6 and 10 [3] heat shockprotein 60 [4], nitric oxide [5], and TNF-� and STAT-3 [6]. These authorsalso propose IL1-�, oxygen free radicals, and platelet-activating factor aspotential biological mediators [7].

NEP is a cell-surface metalloprotease that catalyzes and deactivatesproinflammatory peptides and is an appealing therapeutic target for thetreatment of the lung injury associated with pancreatitis or sepsis.Neutralization of NEP worsens both experimental pancreatitis and thecoupled lung injury. In this study, the authors used a murine model ofPALI to test their hypothesis: that NEP antagonism, or its geneticdeletion, would enhance inflammation and pulmonary damage irrespec-tive of the extent of pancreatitic inflammation. Using NEP knockoutmice, the investigators were able to show conclusively that NEP is aninhibitor of pancreatic elastase-induced lung injury, in all probabilityvia degradation of pro-inflammatory mediators, in both models. Theseresults also support the effectiveness of the elastase-induced lung in-jury model in studying respiratory insufficiency associated with acutepancreatitis.

This manuscript is important as it describes NEPs ability to degrade avariety of pro-inflammatory mediators thereby underpinning the salientrole of NEP in PALI. These experiments portend a therapeutic role forneutral endopeptidase in improving the relentless lung injury seen inacute pancreatitis.

David McFadden, M.D.Editor

.021

1 0022-4804/05 $30.00© 2005 Elsevier Inc. All rights reserved.

Page 2: Neutral Endopeptidase Determines the Severity of Pancreatitis-Associated Lung Injury

2 JOURNAL OF SURGICAL RESEARCH: VOL. 128, NO. 1, SEPTEMBER 2005

REFERENCES1. Gallagher, S. F., Yang, J., Baksh, K., et al. Acute pancreatitis induces FasL gene

expression and apoptosis in the liver. J. Surg. Res. 122: 201, 2004.2. Kim, F. H., Hoge, S. G., Lightner, A. M., Grady, E. F., Coelho, A. M., and Kirkwood, K. S.

Activation of nociceptive neurons in T9 and T10 in cerulein pancreatitis. J. Surg. Res.117: 195, 2004.

3. Miyaoka, K., Iwase, M., Suzuki, R., et al. Clinical evaluation of circulating interleukin-6and interleukin-10 levels after surgery-induced inflammation. J. Surg. Res. 125: 144,2005.

4. Pespeni, M., Mackersie, R. C., Lee, H., et al. Serum levels of hsp60 correlate with thedevelopment of acute lung injury after trauma. J. Surg. Res. 125: 144, 2005.

5. Boer, C., Groenveld, A. B., Scheffer, G. J., deLange, J. J., Westerhof, N., and Sipkema, P.Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed ratpulmonary arteries. J. Surg. Res. 2005 May 24; [Epub ahead of print.

6. Davis, L., Frankenberry, K., and McFadden, D. STAT3 induction by LPS and TNF-alphain pancreatic acinar cells. J. Surg. Res. 127: 14, 2005.

7. Day, A.L., Wick, E., Jordan, T.H., et al. Neural endopeptidase determines the severity ofpancreatitis-associated lung injury. J. Surg. Res. 128: 21, 2005.